CONCLUSION
Osteoporosis is one of the major health problems worldwide causing bone
mass reductions resulting in increased fracture risk. The major
treatment strategies include anabolic and anti resorptive drug classes.
Recombinant human Parathyroid Hormone is an anabolic agent more
effective in the treatment of osteoporotic fractures and increasing Bone
Mineral Density (BMD) as compared to Bisphosphonates that are anti
resorptive agents. However in Pakistan Bisphosphonate therapy is
prescribed more often due to cost effectives and easy availability as
compared to rhPTH therapy that is highly expensive and hardly available.